Prostate Cancer Therapeutics Market Size Worth $12.0 Billion By 2025 Prostate Cancer Therapeutics Market

Prostate Cancer Therapeutics Market Forecast Worth $12.0
Billion By 2025
“The global prostate cancer therapeutics market size was valued at USD 7.9 billion in 2016
and is expected to grow at a CAGR of 4.8% over the forecast period”
The global prostate cancer therapeutics market is expected to reach USD 12.0
billion by 2025, according to a new report by Grand View Research, Inc. According to
the American Cancer Society, approximately 1 in 7 men will be diagnosed with prostate
cancer in their lifetime. As per Cancer Research, a government institute, in the UK,
46,690 new cases of prostate cancer were diagnosed out of which 11,287 patients died
in 2014.
Supportive initiatives undertaken by key players in collaboration with various
governments to create more awareness of clinical symptoms about prostate cancer and
availability of screening & diagnostic tests such as Prostate-Specific Antigen (PSA) and
Digital Rectal Exam (DRE) resulting in early detection. Early detection helps in quick and
on time treatment and assists in deciding treatment regimens. In addition, major players
including Astella, Inc., Sanofi, Dendreon Corporation, AstraZeneca, and Johnson &
Johnson are focusing on development of effective and safe therapeutic products to treat
Follow Us: